Commonwealth Equity Services’s Precision BioSciences DTIL Stock Holding History

Commonwealth Equity Services’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$911K	Buy	115,929 +3,258	+3%	+$22.9K	﹤0.01%	2784
2026 Q1	$620K	Buy	112,671 +19,365	+21%	+$89.3K	﹤0.01%	3020
2025 Q4	$388K	Buy	93,306 +37,461	+67%	+$213K	﹤0.01%	3412
2025 Q3	$308K	Buy	55,845 +2,450	+5%	+$11.7K	﹤0.01%	3610
2025 Q2	$224K	Buy	53,395 +16,240	+44%	+$80.1K	﹤0.01%	3827
2025 Q1	$177K	Buy	37,155 +24,462	+193%	+$125K	﹤0.01%	3872
2024 Q4	$48K	Buy	+12,693	New	+$92.7K	﹤0.01%	3985
2022 Q3	–	Sell	-356	Closed	-$17K	–	3689
2022 Q2	$17K	Buy	356 +14	+4%	+$822	﹤0.01%	3582
2022 Q1	$31K	Buy	+342	New	+$46.5K	﹤0.01%	3627

Other funds holding DTIL

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Commonwealth Equity Services's DTIL Position: Q2 2026 in Review

Commonwealth Equity Services increased its Precision BioSciences (DTIL) stake by 2.9% in Q2 2026, buying an estimated $22.9K and bringing the position to 115,929 shares worth $911K. The position accounts for ﹤0.01% of the portfolio, ranked #2784.

Commonwealth Equity Services first reported a position in DTIL in Q1 2022 and has held it in 9 quarters since. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

Commonwealth Equity Services held 115,929 shares of Precision BioSciences worth $911K as of Q2 2026.
Commonwealth Equity Services bought 3,258 Precision BioSciences shares in Q2 2026, an estimated $22.9K.
Precision BioSciences made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #2784 holding.
Commonwealth Equity Services first reported a position in Precision BioSciences in Q1 2022 and has held it in 9 quarters since.
95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.